An Ethically Dubious Blood Experiment: RECESS
AHRP is concerned about the ethics and safety of human subjects in a blood storage experiment ( RECESS) sponsored
by the National Heart Lung and Blood Institute.
Clinical Trials
AHRP is concerned about the ethics and safety of human subjects in a blood storage experiment ( RECESS) sponsored
by the National Heart Lung and Blood Institute.
…instead of informed patient consent, doctors too often promoted trial treatments as superior to standard approaches, even when there was no supporting evidence.
The results suggest that the truth may have escaped the usual exclusion criteria. Underlying the commercial success of the new antipsychotics is evidence (usually suppressed) showing that these drugs are both harmful and ineffective even for their approved use.
Commentary by Vera Hassner Sharav February 18, 2002 FYI United States Government Sponsored Genetic Research in Rural China Raises Troubling Ethical Concerns A January 2002 report in China Daily, byXiong Lei, the senior journalist with China Features, Xinhua News Agency(below), raises troubling ethical concerns about U.S. government-sponsoredgenetic research in rural…
AHRP Letter to Editor re: ARDS published NEJM Fri, 11 Jul 2003 A truncated version of a Letter to the editor submitted by John H. Noble, Jr., PhD and Vera Sharav appears in the current July 10, 2003, issue of The New England Journal of Medicine. Note: On April 3,…
Another Child Devloped Cancer: SCID Trials Suspended – ABC Tue, 14 Jan 2003 ABC News reports that the FDA suspended 30 gene therapy trials after a second child developed leukemia. So far, two boys who had undergone the experimental gene therapy treatment for immunodeficiency, “bubble boy disease” — or SCID–developed…
AIR: America’s Investigative Reports, is a new Public Broadcasting System (PBS) series whose first report, "A Bitter Pill," airs Friday, Sept. 8.
A team of researchers from Columbia University and the University of Toronto, headed by Dr. Timothy Walsh (New York) tested the effect of antidepressants in the treatment of anorexia in a placebo controlled randomized trial.
The pharmaceutical industry’s dilemma: there are few volunteers in the drug-consuming prosperous countries–so they have taken half their business to underdeveloped countries.
The Boston Globe reports (below): “More than 50 years after psychiatrists began widely dispensing drugs to treat mental illness, the profession is coming face to face with a humbling reality: Its treatments often fail, leaving millions of patients [ ] to suffer while doctors search for something that works.”
Big Pharma by Jacky Law reveals that in essence, most of the pharmaceutical industry’s claims are false; it is not the drug, but the placebo effect whose potency deserves almost all of the credit for any health improvement:
AHRP Testimonies and Presentations Sep 8, 2005: AHRP Testimony: NYS Hearing –AIDS Drug /Vaccine Experiments on Foster Children July 18, 2005: Cheaper than Chimpanzees Statement by Vera Hassner Sharav before the Committee on Ethical Consideration for Revisions to DHHS Regulations on Protection of Prisoners Involved in Research July 2- 8, 2005:…